|
|
|
MIRA INFORM REPORT
|
Report No. : |
487227 |
|
Report Date : |
19.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
BAYER PHARMA AKTIENGESELLSCHAFT |
|
|
|
|
Registered Office : |
Müllerstr. 178, D 13353 Berlin |
|
|
|
|
Country : |
Germany |
|
|
|
|
Year of Establishment : |
1871 |
|
|
|
|
Com. Reg. No.: |
HRB 283 B |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
· Rendering of agricultural services in the field of plant cultivation · Rendering of agricultural services in the field of animal Husbandry · Manufacture of pharmaceutical preparations · Other manufacturing n.e.c |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and a large increase in net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms.
Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II. The German Government introduced a minimum wage in 2015 that increased to $9.79 (8.84 euros) in January 2017.
Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2016 Germany reached a budget surplus of 0.6%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016, though the target was already reached in 2012.
The German economy suffers from low levels of investment, and a government plan to invest 15 billion euros during 2016-18, largely in infrastructure, is intended to spur needed private investment. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany plans to replace nuclear power largely with renewable energy, which accounted for 29.5% of gross electricity consumption in 2016, up from 9% in 2000. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production. Domestic consumption, bolstered by low energy prices and a weak euro, and exports are likely to drive German GDP growth again in 2017.
|
Source
: CIA |
Company
name and address
BAYER PHARMA
AKTIENGESELLSCHAFT
Company Status: Active
Müllerstr. 178
D 13353 Berlin
Telephone:030/468-1111
Telefax: 030/468-15305
E-mail: info@pharma.bayer.com
Company
summary
LEGAL FORM Public limited company
Date of foundation: 1871
Registered on: 02.01.1937
Commercial Register: Local court 14057 Berlin
Under: HRB 283 B
Share
capital
EUR 194,001,000.00
Shareholder:
Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
D 51373 Leverkusen
Legal form: Public limited company
Share capital: EUR 2,116,986,388.48
Share: 100.000 %
Registered on: 15.01.1952
Reg. data: 50939 Köln, HRB 48248
Company lease agreement
Member of the Board of Directors:
Julio Triana
D 13353 Berlin
born: 21.09.1965
Member of the Board of Directors:
Oliver Rittgen
D 51427 Bergisch Gladbach
born: 20.03.1973
Member of the Supervisory Board:
Dirk Rosenberg
D 42103 Wuppertal
born: 04.05.1967
Profession: Businessman
Member of the Supervisory Board:
Peter Müller
D 51469 Bergisch Gladbach
born: 22.01.1960
Profession: Businessman
Marital status: unknown
Member of the Supervisory Board:
Dr. Gabriel Harnier
Gravelottestr. 3
D 40476 Düsseldorf
born: 10.09.1971
Further functions/participations of Oliver Rittgen (Member of the
Board of Directors)
Manager:
Bayer Gesellschaft für Beteiligungen mbH
Kaiser-Wilhelm-Allee 20
D 51373 Leverkusen
Legal form: Private limited company
Share capital: EUR 64,400,000.00
Registered
on: 21.01.1999
Reg. data: 50939 Köln, HRB 49460
COMPANY
HISTORY
Company name and legal form
21.12.2006 - 01.07.2011 Bayer Schering Pharma Aktiengesellschaft
Müllerstr. 178
D 13353 Berlin
Public limited company
10.03.1965 - 20.12.2006 Schering Aktiengesellschaft
Müllerstr. 178
D 13353 Berlin
Public limited company
02.01.1937 - 09.03.1965 Schering Aktiengesellschaft
Müllerstr. 170-178
D 13353 Berlin
Public limited company
RESIGNED ACTING PERSONS AND SHAREHOLDERS
06.04.2017 - 08.09.2017 Member of the Board of Directors
Dr. Miriam Holstein
D 51067 Köln
26.02.2016 - 04.04.2017 Member of the Board of Directors
Dr. Christoph Bertram
D 13353 Berlin
29.08.2014 - 04.04.2017 President of the Board of Directors
Dieter Weinand
D 13353 Berlin
09.06.2016 - 03.02.2017 Member of the Supervisory Board
Manfred Vehreschild
D 51371 Leverkusen
02.03.2016 - 03.02.2017 President of the Supervisory Board
Dr. Hartmut Klusik
D 51377 Leverkusen
02.03.2016 - 03.02.2017 Member of the Supervisory Board
Dr. Armin Knors
D 47798 Krefeld
06.07.2015 - 03.02.2017 Member of the Supervisory Board
Vera Hahn
D 42799 Leichlingen
11.11.2014 - 03.02.2017 Vice-president of the Supervisory Board
Yüksel Karaaslan
D 16562 Hohen Neuendorf
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Heinz-Georg Webers
Wacholderweg 9
D 59192 Bergkamen
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Anita Stapel
D 51371 Leverkusen
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Frank Fulbrecht
Sperberstr. 12
D 13505 Berlin
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Oliver Zühlke
D 42655 Solingen
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Dr. Alexander Rosar
D 50679 Köln
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Dr. Klaus Rau
D 13353 Berlin
11.11.2014 - 03.02.2017 Member of the Supervisory Board
Cornelia Streich
D 42105 Wuppertal
23.07.2014 - 03.02.2017 Member of the Supervisory Board
Dr. Tim Bielfeldt
D 50667 Köln
10.04.2014 - 03.02.2017 Member of the Supervisory Board
Willy Beumann
D 42103 Wuppertal
10.09.2012 - 03.02.2017 Member of the Supervisory Board
Oliver Heinrich
D 15537 Grünheide
10.04.2014 - 02.11.2016 Member of the Supervisory Board
Dr. Roland Hartwig
D 51427 Bergisch Gladbach
09.07.2015 - 23.02.2016 Member of the Board of Directors
Dr. Hartmut Klusik
D 51377 Leverkusen
18.04.2011 - 23.02.2016 Member of the Board of Directors
Manfred Vehreschild
D 51371 Leverkusen
23.07.2014 - 07.01.2016 President of the Supervisory Board
Michael König
D 51373 Leverkusen
12.10.2010 - 07.01.2016 Member of the Supervisory Board
Dr. Dirk Van Meirvenne
D 56729 Langenfeld
11.11.2014 - 01.06.2015 Member of the Supervisory Board
Ian Paterson
D 40210 Düsseldorf
11.11.2014 - 02.03.2015 Member of the Supervisory Board
Dr. Olivier Brandicourt
D 40210 Düsseldorf
BUSINESS
ACTIVITIES
SECTORS
01610 Rendering of agricultural services in the field of plant cultivation
01620 Rendering of agricultural services in the field of animal husbandry
21200 Manufacture of pharmaceutical preparations
32990 Other manufacturing n.e.c.
BRANCHES
AND FACTORIES
Works:
Bayer Pharma Aktiengesellschaft
Ernst-Schering-Str. 14
D 59192 Bergkamen
TEL.: 02307/650
FAX.: 02307/69381
PARTICIPATIONS
Limited partner:
Jenapharm GmbH & Co. KG
Otto-Schott-Str. 15
D 07745 Jena
Legal form: Ltd partnership with priv. ltd.
company as general partner
Company Status: active
Total cap. EUR 21,000,000.00
contribution:
Share: EUR 21,000,000.00
Reg. data: 08.10.1996
Local court 07745 Jena
HRA 201386
Limited partner:
Alcafleu Management GmbH & Co. KG
Lilienthalstr. 4
D 12529 Schönefeld
Legal form: Ltd partnership with priv. ltd.
company as general partner
Company Status: active
Total cap. EUR 1,000,000.00
contribution:
Share: EUR 999,999.00
Reg. data: 04.09.2009
Local court 03044 Cottbus
HRA 2580 CB
Limited partner:
Sechste Bayer Real Estate VV GmbH & Co. KG
Lilienthalstr. 4 OT
Waltersdorf
D 12529 Schönefeld
Legal form: Ltd partnership with priv. ltd.
company as general partner
Company Status: active
Total cap. EUR 100,000.00
contribution:
Share: EUR 100,000.00
Reg. data: 01.10.2013
Local court 03044 Cottbus
HRA 2858 CB
Limited partner:
High-Tech Gründerfonds II GmbH & Co. KG
Schlegelstr. 2
D 53113 Bonn
Legal form: Ltd partnership with priv. ltd.
company as general partner
Company Status: active
Total cap. EUR 304,100.00
contribution:
Share: EUR 2,500.00
Reg. data: 07.11.2011
Local court 53111 Bonn
HRA 7844
Shareholder:
Bayer Gesellschaft für Beteiligungen mbH
Kaiser-Wilhelm-Allee 20
D 51373 Leverkusen
Legal form: Private limited company
Company Status: active
Share capital: EUR 64,400,000.00
Share: EUR 32,292,900.00
Reg. data: 21.01.1999
Local court 50939 Köln
HRB 49460
Shareholder:
Steigerwald Arzneimittelwerk GmbH
Havelstr. 5
D 64295 Darmstadt
Legal form: Private limited company
Company Status: active
Share capital: EUR 4,700,000.00
Share: EUR 4,700,000.00
Reg. data: 18.06.1956
Local court 64283 Darmstadt
HRB 1124
Shareholder:
Bayer Vital GmbH
Kaiser-Wilhelm-Allee 70
D 51373 Leverkusen
Legal form: Private limited company
Company Status: active
Share capital: EUR 1,600,000.00
Share: EUR 1,600,000.00
Reg. data: 15.11.1996
Local court 50939 Köln
HRB 49226
Shareholder:
Intendis GmbH
Lilienthalstr. 4 OT
Waltersdorf
D 12529 Schönefeld
Legal form: Private limited company
Company Status: active
Share capital: EUR 50,000.00
Share: EUR 50,000.00
Reg. data: 20.04.2001
Local court 14057 Berlin
HRB 79750 B
Shareholder:
Medrad Medizinische Systeme GmbH
Kaiser-Wilhelm-Allee 70
D 51373 Leverkusen
Legal form: Private limited company
Company Status: dissolved
since: 21.05.2015
Share capital: EUR 25,564.59
Share: EUR 25,564.59
Reg. data: 28.03.2013
Local court 50939 Köln
HRB 78113
Shareholder:
Bayer Altersversorgung GmbH
Kaiser-Wilhelm-Allee 10
D 51373 Leverkusen
Legal form: Private limited company
Company Status: active
Share capital: EUR 26,000.00
Share: EUR 26,000.00
Reg. data: 20.08.2004
Local court 50939 Köln
HRB 53571
Shareholder:
Berlax Verwaltungsgesellschaft mbH
Elsässer Str. 20n
D 79110 Freiburg
Legal form: Private limited company
Company Status: active
Share capital: EUR 25,564.59
Share: EUR 25,564.59
Reg. data: 20.07.1994
Local court 14057 Berlin
HRB 52163
Shareholder:
GP Grenzach Produktions GmbH
Emil-Barell-Str. 7
D 79639 Grenzach-Wyhlen
Legal form: Private limited company
Company Status: active
Share capital: EUR 25,000.00
Share: EUR 25,000.00
Reg. data: 11.03.2003
Local court 79098 Freiburg
HRB 413629
Shareholder:
BBB Management GmbH Campus Berlin-Buch
Robert-Rössle-Str. 10
D 13125 Berlin
Legal form: Private limited company
Company Status: active
Share capital: EUR 25,564.60
Share: EUR 5,112.92
Reg. data: 15.12.1995
Local court 14057 Berlin
HRB 57456 B
Shareholder:
Bayer Schering Pharma Aktiengesellschaft
Müllerstr. 178
D 13353 Berlin
Legal form: Public limited company
Company Status: active
Share capital: EUR 92,000,000.00
Share: 100.000 %
Reg. data: 10.08.2006
Local court 14057 Berlin
HRB 103188 B
FINANCIAL
INFORMATION
Payment experience: in top condition
Negative information: We have no negative information at hand.
REAL
ESTATE
Type of ownership: proprietor
Share: 100.00 %
Address Müllerstr. 178
D 13353 Berlin
Land register documents were not available.
BANKERS
Principal bank
COMMERZBANK FILIALE BERLIN 2, 10891 BERLIN
Sort. code: 12040000
BIC: COBADEBB120
FINANCIAL
FIGURES
Financial year: 01.01. - 31.12.
The number of employees is not known.
Company lease agreement to:
Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
D 51373 Leverkusen
There may have been some changes since our last research took place. Therefore, a freshly researched report will follow shortly.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 63.84 |
|
|
1 |
INR 88.28 |
|
Euro |
1 |
INR 77.88 |
|
EUR |
1 |
INR 78.06 |
Note:
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.